<p class="MsoNormal">Listen to episode twenty-three to hear Karen, and our guests dissect the findings from the latest annual R&D ROI Report which launched last month. This report has provided insights into the state of biopharma R&D since 2010. We have expanded the analysis over time and our data set now covers the top 20 pharma companies by R&D spend</p>

Listen to episode twenty-three to hear Karen, and our guests dissect the findings from the latest annual R&D ROI Report which launched last month. This report has provided insights into the state of biopharma R&D since 2010. We have expanded the analysis over time and our data set now covers the top 20 pharma companies by R&D spend

<p>Listen to episode twenty-three to hear Karen, and our guests dissect the findings from the latest annual R&amp;D ROI Report which launched last month. This report has provided insights into the state of biopharma R&amp;D since 2010. We have expanded the analysis over time and our data set now covers the top 20 pharma companies by R&amp;D spend</p>

Measuring the return from pharmaceutical innovation report 2022

Life Sciences Connect explores the big issues, the emerging trends and the cutting edge innovations that are shaping the Life Sciences industry. Each month, we will connect with industry experts and leaders from the Biotech, Pharmaceutical and Medical Devices industries to discuss how key trends, explored in our research reports, are charting a new, sustainable future for the Life Sciences Industry.

Share Measuring the return from pharmaceutical innovation report 2022

Sign up to save your podcasts

Measuring the return from pharmaceutical innovation report 2022

Measuring the return from pharmaceutical innovation report 2022

More shows like Life Sciences Connect

Today in Focus